Concepedia

Mahan Moshir

MM

8

Publications

462

Citations

8

H-Index

2013

Active since

Affiliations

Ablynx (Belgium)(Current)

University Hospital of Zurich

Institut Jules Bordet

Ghent University Hospital

University of Bern

Mahan Moshir is an author at Ablynx (Belgium) specializing in immunology, autoimmunity, and medicine.

Top concepts

Publications per year

2013–2021

8

Publications

8

Targeting CD70 with cusatuzumab eliminates acute myeloid leukemia stem cells in patients treated with hypomethylating agents

Carsten Riether, Thomas Pabst, Sabine Höpner et al. · Nature Medicine · 2020 · 199 citations

, , +7

ARGX-110, a highly potent antibody targeting CD70, eliminates tumors via both enhanced ADCC and immune checkpoint blockade

Karen Silence, Torsten Dreier, Mahan Moshir et al. · mAbs · 2013 · 100 citations · Full text

, , +18

Phase I Dose-Escalation Study of the Anti-CD70 Antibody ARGX-110 in Advanced Malignancies

Philippe Aftimos, Christian Rolfo, Sylvie Rottey et al. · Clinical Cancer Research · 2017 · 62 citations

Cusatuzumab for treatment of CD70‐positive relapsed or refractory cutaneous T‐cell lymphoma

Nicolas Leupin, Pier Luigi Zinzani, Franck Morschhauser et al. · Cancer · 2021 · 32 citations

A novel llama antibody targeting Fn14 exhibits anti-metastatic activity in vivo

Johannes Trebing, Isabell Lang, Martin Chopra et al. · mAbs · 2013 · 26 citations · Full text

Rows per page

1–5 of 8